Lower Platelet Aggregation Is a Risk Factor for Dual Antiplatelet Therapy-Associated Bleeding: A Preliminary Retrospective Study with Genotype Analysis

BACKGROUND: The purpose of this study was to investigate factors influencing bleeding in patients with acute coronary syndrome (ACS) who are on aspirin and ticagrelor as dual antiplatelet therapy. MATERIAL/METHODS: This retrospective case-control study included 50 patients with ACS (25 with reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Dongdong, Shi, Xiangfen, Guo, Liping, Wang, Gaobiao, Zhao, Yujie, Yang, Yuling, Zhang, Hanjuan, Huang, Qiong, Yuan, Yiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318838/
https://www.ncbi.nlm.nih.gov/pubmed/32541641
http://dx.doi.org/10.12659/MSM.923758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318838/
https://www.ncbi.nlm.nih.gov/pubmed/32541641
http://dx.doi.org/10.12659/MSM.923758

Ejemplares similares